electroCore (ECOR) Debt Ratio (2020 - 2026)
electroCore (ECOR) posted quarterly Debt Ratio of 0.43 for Q1 2026, up 22.03% quarter-over-quarter from 0.35 in Q4 2025.
electroCore (ECOR) Debt Ratio (2020 - 2026) Analysis & Trends
electroCore's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.43 for Q1 2026.
- In Q1 2026, Debt Ratio changed N/A year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (changed N/A YoY), while the FY2025 annual figure was 0.35, changed N/A from the prior year.
- Debt Ratio for Q1 2026 stood at 0.43, up from 0.35 in the prior quarter.
- The five-year high for Debt Ratio was 0.43 in Q1 2026, with the low at 0.3 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 0.18 |
| 10 | electroCore | 93.04 Mn | 83.00 Mn | 8.18 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.35 |
| Sep 30, 2025 | 0.30 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.03 |